151 related articles for article (PubMed ID: 9914475)
1. The role of the fourth extracellular domain of the rat corticotropin-releasing factor receptor type 1 in ligand binding.
Sydow S; Flaccus A; Fischer A; Spiess J
Eur J Biochem; 1999 Jan; 259(1-2):55-62. PubMed ID: 9914475
[TBL] [Abstract][Full Text] [Related]
2. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
Myers DA; Trinh JV; Myers TR
Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
[TBL] [Abstract][Full Text] [Related]
3. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.
Dautzenberg FM; Kilpatrick GJ; Wille S; Hauger RL
J Neurochem; 1999 Aug; 73(2):821-9. PubMed ID: 10428081
[TBL] [Abstract][Full Text] [Related]
4. Structure-function relationship of different domains of the rat corticotropin-releasing factor receptor.
Sydow S; Radulovic J; Dautzenberg FM; Spiess J
Brain Res Mol Brain Res; 1997 Dec; 52(2):182-93. PubMed ID: 9495539
[TBL] [Abstract][Full Text] [Related]
5. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
Dautzenberg FM; Wille S
Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
[TBL] [Abstract][Full Text] [Related]
6. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.
Wille S; Sydow S; Palchaudhuri MR; Spiess J; Dautzenberg FM
J Neurochem; 1999 Jan; 72(1):388-95. PubMed ID: 9886092
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.
Dautzenberg FM; Wille S; Lohmann R; Spiess J
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4941-6. PubMed ID: 9560207
[TBL] [Abstract][Full Text] [Related]
8. Novel high-affinity photoactivatable antagonists of corticotropin-releasing factor (CRF) photoaffinity labeling studies on CRF receptor, type 1 (CRFR1).
Bonk I; Rühmann A
Eur J Biochem; 2000 May; 267(10):3017-24. PubMed ID: 10806401
[TBL] [Abstract][Full Text] [Related]
9. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
Gordon JC; Edwards P; Elmore CS; Lazor LA; Paschetto K; Bostwick R; Sylvester M; Mauger R; Scott C; Aharony D
Eur J Pharmacol; 2010 Dec; 649(1-3):59-63. PubMed ID: 20854803
[TBL] [Abstract][Full Text] [Related]
10. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
11. Five amino acids of the Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart.
Dautzenberg FM; Higelin J; Brauns O; Butscha B; Hauger RL
Mol Pharmacol; 2002 May; 61(5):1132-9. PubMed ID: 11961131
[TBL] [Abstract][Full Text] [Related]
12. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor.
Xiong Y; Xie LY; Abou-Samra AB
Endocrinology; 1995 May; 136(5):1828-34. PubMed ID: 7720627
[TBL] [Abstract][Full Text] [Related]
13. Homologous desensitization of human corticotropin-releasing factor1 receptor in stable transfected mouse fibroblast cells.
Dieterich KD; Grigoriadis DE; De Souza EB
Brain Res; 1996 Feb; 710(1-2):287-92. PubMed ID: 8963673
[TBL] [Abstract][Full Text] [Related]
14. The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors.
Perrin MH; Grace CR; Riek R; Vale WW
Ann N Y Acad Sci; 2006 Jul; 1070():105-19. PubMed ID: 16888152
[TBL] [Abstract][Full Text] [Related]
15. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
Perrin MH; Sutton S; Bain DL; Berggren WT; Vale WW
Endocrinology; 1998 Feb; 139(2):566-70. PubMed ID: 9449626
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.
Rühmann A; Bonk I; Lin CR; Rosenfeld MG; Spiess J
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15264-9. PubMed ID: 9860957
[TBL] [Abstract][Full Text] [Related]
17. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution.
Palchaudhuri MR; Wille S; Mevenkamp G; Spiess J; Fuchs E; Dautzenberg FM
Eur J Biochem; 1998 Nov; 258(1):78-84. PubMed ID: 9851694
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP).
Miyamoto Y; Habata Y; Ohtaki T; Masuda Y; Ogi K; Onda H; Fujino M
Biochim Biophys Acta; 1994 Aug; 1218(3):297-307. PubMed ID: 8049255
[TBL] [Abstract][Full Text] [Related]
20. Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction.
Assil IQ; Qi LJ; Arai M; Shomali M; Abou-Samra AB
Biochemistry; 2001 Feb; 40(5):1187-95. PubMed ID: 11170443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
